{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-3048"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-3048","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"In vitro dihalobenzene nephrotoxicity in isolated kidney cells","abstract":"Brominated and chlorinated benzenes are common industrial chemicals linked to kidney injury. This study evaluated the nephrotoxicity of several mono- and dihalogenated derivatives using isolated kidney cells from male Fischer 344 rats. LDH release and trypan blue exclusion were measured after 30- and 60-minute exposures to 0.25–1.0 mM to test compounds. Toxicity increased with increased concentration and longer times. Mixed-halogen bromobenzenes, particularly 1-bromo-4-chlorobenzene, showed one of the highest toxicity levels, while 1,4dichlorobenzene was the most toxic chlorobenzene. Antioxidants (glutathione, ascorbate, and αtocopherol) markedly reduced injury, indicating oxidative mechanisms play a role in toxicity. cytochromes P450 (CYP) inhibitors (piperonyl butoxide and metyrapone) decreased toxicity, demonstrating that metabolic activation contributed to cell damage. Deferoxamine reduced injury by limiting iron-driven radical formation. These findings show that halogen substitution patterns strongly influence cytotoxicity and that oxidative stress and CYP-dependent metabolism drive the nephrotoxic response to dihalobenzene exposure.","abstract_html":"Brominated and chlorinated benzenes are common industrial chemicals linked to kidney injury. This study evaluated the nephrotoxicity of several mono- and dihalogenated derivatives using isolated kidney cells from male Fischer 344 rats. LDH release and trypan blue exclusion were measured after 30- and 60-minute exposures to 0.25–1.0 mM to test compounds. Toxicity increased with increased concentration and longer times. Mixed-halogen bromobenzenes, particularly 1-bromo-4-chlorobenzene, showed one of the highest toxicity levels, while 1,4dichlorobenzene was the most toxic chlorobenzene. Antioxidants (glutathione, ascorbate, and αtocopherol) markedly reduced injury, indicating oxidative mechanisms play a role in toxicity. cytochromes P450 (CYP) inhibitors (piperonyl butoxide and metyrapone) decreased toxicity, demonstrating that metabolic activation contributed to cell damage. Deferoxamine reduced injury by limiting iron-driven radical formation. These findings show that halogen substitution patterns strongly influence cytotoxicity and that oxidative stress and CYP-dependent metabolism drive the nephrotoxic response to dihalobenzene exposure.","abstract_has_math":false,"creators":["Sherif, Jana Ahmed"],"institution":null,"degree_name":"Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"School of Pharmacy","degree_department":null,"school":null,"contributors":["Dr. Gary O. Rankin","Dr. Monica Valentovic","Dr. Michael Hambuchen"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:30Z","subjects":["Medical Sciences","Medical Toxicology","Pharmacy and Pharmaceutical Sciences","kindney","nephrotoxicity","dihalobenzene","toxicity"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/2043","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/2043","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-3048","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Gary O. Rankin","Dr. Monica Valentovic","Dr. Michael Hambuchen"]},{"key":"dc:creator","label":"Author","values":["Sherif, Jana Ahmed"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-04-16T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2026-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["School of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Sciences","Medical Toxicology","Pharmacy and Pharmaceutical Sciences","kindney","nephrotoxicity","dihalobenzene","toxicity"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/2043"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Brominated and chlorinated benzenes are common industrial chemicals linked to kidney injury. This study evaluated the nephrotoxicity of several mono- and dihalogenated derivatives using isolated kidney cells from male Fischer 344 rats. LDH release and trypan blue exclusion were measured after 30- and 60-minute exposures to 0.25–1.0 mM to test compounds. Toxicity increased with increased concentration and longer times. Mixed-halogen bromobenzenes, particularly 1-bromo-4-chlorobenzene, showed one of the highest toxicity levels, while 1,4dichlorobenzene was the most toxic chlorobenzene. Antioxidants (glutathione, ascorbate, and αtocopherol) markedly reduced injury, indicating oxidative mechanisms play a role in toxicity. cytochromes P450 (CYP) inhibitors (piperonyl butoxide and metyrapone) decreased toxicity, demonstrating that metabolic activation contributed to cell damage. Deferoxamine reduced injury by limiting iron-driven radical formation. These findings show that halogen substitution patterns strongly influence cytotoxicity and that oxidative stress and CYP-dependent metabolism drive the nephrotoxic response to dihalobenzene exposure."]},{"key":"dc:title","label":"Title","values":["In vitro dihalobenzene nephrotoxicity in isolated kidney cells"]}]}],"canonical_facts":{"dc:contributor":["Dr. Gary O. Rankin","Dr. Monica Valentovic","Dr. Michael Hambuchen"],"dc:creator":["Sherif, Jana Ahmed"],"dc:date.available":["2026-04-16T07:00:00Z"],"dc:date.created":["2026-01-01T08:00:00Z"],"dc:description.abstract":["Brominated and chlorinated benzenes are common industrial chemicals linked to kidney injury. This study evaluated the nephrotoxicity of several mono- and dihalogenated derivatives using isolated kidney cells from male Fischer 344 rats. LDH release and trypan blue exclusion were measured after 30- and 60-minute exposures to 0.25–1.0 mM to test compounds. Toxicity increased with increased concentration and longer times. Mixed-halogen bromobenzenes, particularly 1-bromo-4-chlorobenzene, showed one of the highest toxicity levels, while 1,4dichlorobenzene was the most toxic chlorobenzene. Antioxidants (glutathione, ascorbate, and αtocopherol) markedly reduced injury, indicating oxidative mechanisms play a role in toxicity. cytochromes P450 (CYP) inhibitors (piperonyl butoxide and metyrapone) decreased toxicity, demonstrating that metabolic activation contributed to cell damage. Deferoxamine reduced injury by limiting iron-driven radical formation. These findings show that halogen substitution patterns strongly influence cytotoxicity and that oxidative stress and CYP-dependent metabolism drive the nephrotoxic response to dihalobenzene exposure."],"dc:identifier":["https://mds.marshall.edu/etd/2043"],"dc:subject":["Medical Sciences","Medical Toxicology","Pharmacy and Pharmaceutical Sciences","kindney","nephrotoxicity","dihalobenzene","toxicity"],"dc:title":["In vitro dihalobenzene nephrotoxicity in isolated kidney cells"],"thesis:degree_discipline":["School of Pharmacy"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Pharmaceutical Sciences"]},"updated_at":"2026-11-21T19:58:30Z"}